GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Price-to-Free-Cash-Flow

BetterLife Pharma (STU:NPAU) Price-to-Free-Cash-Flow : N/A (As of Jun. 01, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Price-to-Free-Cash-Flow?

As of today (2024-06-01), BetterLife Pharma's share price is €0.0805. BetterLife Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Oct. 2023 was €-0.02. Hence, BetterLife Pharma's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for BetterLife Pharma's Price-to-Free-Cash-Flow or its related term are showing as below:

STU:NPAU's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.975
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

BetterLife Pharma's Free Cash Flow per Share for the three months ended in Oct. 2023 was €-0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €-0.02.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 68.80% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 29.20% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -39.60% per year.

During the past 13 years, BetterLife Pharma's highest 3-Year average Free Cash Flow per Share Growth Rate was 68.80% per year. The lowest was -176.90% per year. And the median was -22.85% per year.


BetterLife Pharma Price-to-Free-Cash-Flow Historical Data

The historical data trend for BetterLife Pharma's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Price-to-Free-Cash-Flow Chart

BetterLife Pharma Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BetterLife Pharma Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BetterLife Pharma's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, BetterLife Pharma's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Price-to-Free-Cash-Flow falls into.



BetterLife Pharma Price-to-Free-Cash-Flow Calculation

BetterLife Pharma's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.0805/-0.015
=N/A

BetterLife Pharma's Share Price of today is €0.0805.
BetterLife Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

BetterLife Pharma  (STU:NPAU) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


BetterLife Pharma Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma (STU:NPAU) Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines